Sculptra (Under-Eye)

• The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation.
• Its approach differs from immediate filling with HA. PLLA cannot be dissolved with hyaluronidase, so conservative planning matters. Under-eye darkness may involve hollows, protruding fat, pigmentation or skin quality. Product instructions, eyelid function and previous treatments guide suitability. Inclusion in this menu does not mean every product is injected directly under the eyes. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation.

Suitability requires an examination. Skin thickness, health and previous procedures may make a different approach more appropriate.

• 01

  Where you are now, and where we start

  The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation.

• 02

  The change you want, the impression you keep

  The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation. Its approach differs from immediate filling with HA. PLLA cannot be dissolved with hyaluronidase, so conservative planning matters. Under-eye darkness may involve hollows, protruding fat, pigmentation or skin quality. Product instructions, eyelid function and previous treatments guide suitability. Inclusion in this menu does not mean every product is injected directly under the eyes. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation.

• 03

  How it differs from similar options

  Its approach differs from immediate filling with HA. PLLA cannot be dissolved with hyaluronidase, so conservative planning matters.

• 04

  Health information and recovery schedule

  Injection marks, redness, swelling, bruising, tenderness or temporary bumps can occur; recovery varies. Persistent swelling or discomfort should be assessed before further treatment. Keep these product differences in mind when discussing your aftercare. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation. Avoid strong irritation, overheating and strenuous exercise while the skin settles. Follow your instructions for washing and makeup. Massage and pressure advice differs by product. Follow your clinician’s instructions rather than another product’s routine. Temporary injection bumps differ from persistent or delayed nodules. Seek review for a firm lump that persists, grows, hurts or becomes red. Non-HA materials such as PDLLA cannot be dissolved with hyaluronidase like HA filler.

Sculptra

Sculptra is a poly-L-lactic acid (PLLA) injectable that stimulates collagen formation. Planning focuses on gradual tissue change rather than immediate fullness. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation. Under-eye darkness may involve hollows, protruding fat, pigmentation or skin quality. Product instructions, eyelid function and previous treatments guide suitability. Inclusion in this menu does not mean every product is injected directly under the eyes.

How it works

• 01

  The product and material

  Sculptra is a poly-L-lactic acid (PLLA) injectable that stimulates collagen formation. Planning focuses on gradual tissue change rather than immediate fullness. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation.

• 02

  Your starting point

  The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation.

• 03

  What sets it apart

  Its approach differs from immediate filling with HA. PLLA cannot be dissolved with hyaluronidase, so conservative planning matters.

• 04

  Assessing the change

  Collagen-stimulating treatments are assessed over weeks to months. Fullness on the treatment day does not establish the final effect. Session count and spacing depend on examination, the specific product instructions and your response. Allow recovery time before an important event or journey.

1. 01

   Start with the concern

   Its approach differs from immediate filling with HA. PLLA cannot be dissolved with hyaluronidase, so conservative planning matters. Under-eye darkness may involve hollows, protruding fat, pigmentation or skin quality. Product instructions, eyelid function and previous treatments guide suitability. Inclusion in this menu does not mean every product is injected directly under the eyes. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation.

2. 02

   Understand your product

   Its approach differs from immediate filling with HA. PLLA cannot be dissolved with hyaluronidase, so conservative planning matters.

3. 03

   Plan through recovery

   Before deciding on another session, we review progress toward these particular goals. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation. Collagen-stimulating treatments are assessed over weeks to months. Fullness on the treatment day does not establish the final effect. Session count and spacing depend on examination, the specific product instructions and your response. Allow recovery time before an important event or journey.

What the procedure is like

• Injection marks, redness, swelling, bruising, tenderness or temporary bumps can occur; recovery varies. Persistent swelling or discomfort should be assessed before further treatment. Keep these product differences in mind when discussing your aftercare. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation.
• Avoid strong irritation, overheating and strenuous exercise while the skin settles. Follow your instructions for washing and makeup.
• Massage and pressure advice differs by product. Follow your clinician’s instructions rather than another product’s routine.
• Temporary injection bumps differ from persistent or delayed nodules. Seek review for a firm lump that persists, grows, hurts or becomes red. Non-HA materials such as PDLLA cannot be dissolved with hyaluronidase like HA filler.

Safety & considerations

Worsening pain, pale or mottled skin, visual symptoms or breathing difficulty need urgent medical attention. Outcomes and duration vary; a specific result is not guaranteed.

1. Immediately

   Initial swelling and fullness are not the final result.

2. Early recovery

   Temporary injection bumps differ from persistent or delayed nodules. Seek review for a firm lump that persists, grows, hurts or becomes red. Non-HA materials such as PDLLA cannot be dissolved with hyaluronidase like HA filler.

3. Review

   Collagen-stimulating treatments are assessed over weeks to months. Fullness on the treatment day does not establish the final effect.

4. Next steps

   Plan any further session only after assessing the response and recovery.

• Q. What is Sculptra used for in the under-eye area?

  Sculptra is a poly-L-lactic acid (PLLA) injectable that stimulates collagen formation. Planning focuses on gradual tissue change rather than immediate fullness. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation.

• Q. Is Sculptra suitable for my under-eye area?

  Its approach differs from immediate filling with HA. PLLA cannot be dissolved with hyaluronidase, so conservative planning matters. Under-eye darkness may involve hollows, protruding fat, pigmentation or skin quality. Product instructions, eyelid function and previous treatments guide suitability. Inclusion in this menu does not mean every product is injected directly under the eyes.

• Q. How many under-eye Sculptra sessions will I need?

  Before deciding on another session, we review progress toward these particular goals. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation. Collagen-stimulating treatments are assessed over weeks to months. Fullness on the treatment day does not establish the final effect. Session count and spacing depend on examination, the specific product instructions and your response. Allow recovery time before an important event or journey.

• Q. What is recovery and aftercare like after Sculptra around the eyes?

  Injection marks, redness, swelling, bruising, tenderness or temporary bumps can occur; recovery varies. Avoid strong irritation, overheating and strenuous exercise while the skin settles. Follow your instructions for washing and makeup. Massage and pressure advice differs by product. Follow your clinician’s instructions rather than another product’s routine. Temporary injection bumps differ from persistent or delayed nodules. Seek review for a firm lump that persists, grows, hurts or becomes red. Non-HA materials such as PDLLA cannot be dissolved with hyaluronidase like HA filler. Worsening pain, pale or mottled skin, visual symptoms or breathing difficulty need urgent medical attention. Outcomes and duration vary; a specific result is not guaranteed. Persistent swelling or discomfort should be assessed before further treatment. Keep these product differences in mind when discussing your aftercare. Its approach differs from immediate filling with HA. PLLA cannot be dissolved with hyaluronidase, so conservative planning matters.

• Q. How do I choose a clinic for Sculptra in Gangnam, Seoul?

  Look at the examination and the plan rather than the treatment name. First, what the clinic checks before deciding — at QD Clinic in Gangnam, Seoul, the first thing we look at for this treatment is “The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. This page does not establish safety for direct under-eye injection or Korean approval; the intended area needs clinical confirmation”. Second, whether it explains why it recommends that scope and method, compared with the alternatives. Third, whether it reviews your progress with you when results are expected. Our doctor goes through these three points at consultation before the treatment is decided.

• Q. Where can I get Sculptra in Seoul?

  At QD Clinic in Gangnam, Seoul, South Korea. We are at 3F, 502 Gangnam-daero, Gangnam-gu, Seoul (Nonhyeon-dong, Seohee Building), a 4-minute walk from Exit 3 of Nonhyeon or Sinnonhyeon Station. Call +82-2-514-1650 or use the consultation form on this site to book a doctor’s consultation first.